Geiger Roger, PhD

Pubblicazioni

• Metabolic modulation of tumours with engineered bacteria for immunotherapy
  Canale, F. P. Basso, C. Antonini, G. Perotti, M. Li, N. Sokolovska, A. Neumann, J. James, M. J. Geiger, S. Jin, W. Theurillat, J. P. West, K. A. Leventhal, D. S. Lora, J. M. Sallusto, F. Geiger, R.
  in Nature (2021) Vol. pp
  
• Structural basis of malaria RIFIN binding by LILRB1-containing antibodies
  Chen, Y. Xu, K. Piccoli, L. Foglierini, M. Tan, J. Jin, W. Gorman, J. Tsybovsky, Y. Zhang, B. Traore, B. Silacci-Fregni, C. Daubenberger, C. Crompton, P. D. Geiger, R. Sallusto, F. Kwong, P. D. Lanzavecchia, A.
  in Nature (2021) Vol.592 pp639-643
  
• Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin
  Cassotta, A. Paparoditis, P. Geiger, R. Mettu, R. R. Landry, S. J. Donati, A. Benevento, M. Foglierini, M. Lewis, D. J. M. Lanzavecchia, A. Sallusto, F.
  in J Exp Med (2020) Vol.217 ppe20200206
  
• Dynamics in protein translation sustaining T cell preparedness
  Wolf, T. Jin, W. Zoppi, G. Vogel, I. A. Akhmedov, M. Bleck, C. K. E. Beltraminelli, T. Rieckmann, J. C. Ramirez, N. J. Benevento, M. Notarbartolo, S. Bumann, D. Meissner, F. Grimbacher, B. Mann, M. Lanzavecchia, A. Sallusto, F. Kwee, I. Geiger, R.
  in Nat Immunol (2020) Vol.21 pp927-937
  
• A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients
  Cassotta, A. Mikol, V. Bertrand, T. Le Parc, J. Ferrari, P. Dumas, J. Auer, M. Deisenhammer, F. Gastaldi, M. Franciotta, D. Silacci-Fregni, C. Fernandez Rodriguez, B. Giacchetto-Sasselli, I. Foglierini, M. Jarrossay, D. Geiger, R. Sallusto, F. Lanzavecchia, A. Piccoli, L.
  in Nat Med (2019) Vol.25 pp1402-1407
  
• Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)
  Schubert, D. Klein, M. C. Hassdenteufel, S. Yang, L. Proietti, M. Bulashevska, A. Kemming, J. Kuhn, J. Winzer, S. Rusch, S. Fliegauf, M. Schaffer, A. A. Pfeffer, S. Geiger, R. Cavalie, A. Cao, H. Yang, F. Li, Y. Rizzi, M. Eibel, H. Kobbe, R. Marks, A. L. Peppers, B. P. Hostoffer, R. W. Puck, J. M. Zimmermann, R. Grimbacher, B.
  in J Allergy Clin Immunol (2017) Vol.141 pp1427-1438
  
• Social network architecture of human immune cells unveiled by quantitative proteomics
  Rieckmann, J. C. Geiger, R. Hornburg, D. Kveler, K. Jarrossay, D. Sallusto, F. Shen-Orr, S. S. Lanzavecchia, A. Mann, M. Meissner, F.
  in Nat Immunol (2017) Vol.18 pp583-593
  
• L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
  Geiger, R. Rieckmann, J. C. Wolf, T. Feng, Y. Fuhrer, T. Kogadeeva, M. Picotti, P. Meissner, F. Mann, M. Zamboni, N. Sallusto, F. Lanzavecchia, A.
  in Cell (2016) Vol.167 pp829-842 e13
  Geiger R. and Lanzavecchia A are co-corresponding authors.
• Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
  Kabanova, A. Marcandalli, J. Zhou, T. Baxa, U. Tsybovsky, Y. Lilleri, D. Silacci-Fregni, C. Foglierini, M. Fernandez-Rodriguez, B. M. Druz, A. Zhang, B. Geiger, R. Pagani, M. Sallusto, F. Kwong, P. D. Corti, D. Lanzavecchia, A. Perez, L.
  in Nat Microbiol (2016) Vol.1 pp16082
  Anna Kabanova, Jessica Marcandalli, Tongqing Zhou equally contributed to this work; Antonio Lanzavecchia1and Laurent Perez jointly supervised this work.
• A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens
  Tan, J. Pieper, K. Piccoli, L. Foglierini, M. Geiger, R. Tully, C. M. Jarrossay, D. Ndungu, F. M. Wambua, J. Bejon, P. Fregni, C. S. Fernandez-Rodriguez, B. Barbieri, S. Bianchi, S. Marsh, K. Thathy, V. Corti, D. Sallusto, F. Bull, P. Lanzavecchia, A.
  in Nature (2016) Vol.529 pp105-9
  Joshua Tan, Kathrin Pieper, Luca Piccoli equally contributed to this work and Peter Bull and Antonio Lanzavecchia jointly supervised this work.